Skip to main content
Log in

Galectin-3: Cellular Distribution and Correlation with WHO-grade in Human Gliomas

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

In order to elucidate the reason for conflicting results that have been published previously on galectin-3 expression in human gliomas, we used single labeling and double labeling immunohistochemistry experiments to identify cellular origin and extent of galectin-3 positivity in 53 glioma-samples (16 glioblastomas, 21 anaplastic astrocytomas, 16 low-grade astrocytomas). Galectin-3 positivity was observed in neoplastic astrocytes, macrophages/microglial cells, endothelial cells and some B- and T-lymphocytes. The quantitative analysis showed that the percentage of galectin-3 positive cells was significantly higher in the tumor parenchyma of glioblastomas than in anaplastic (p = 0.0371) and low-grade astrocytomas (p = 0.0042). Single labeling with anti-CD68 antibodies revealed a significant correlation between CD68 and galectin-3 immunoreactivity (p = 0.0092). Endothelial cells were labeled in all low-grade and anaplastic astrocytomas, but only in 10/16 glioblastomas (p = 0.0003). This detailed analysis demonstrates that galectin-3 positivity in human gliomas is considerably influenced by tumor-infiltrating macrophages. The differential expression on endothelial cells raises the question if galectin-3 plays a role in tumor angiogenesis of human gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A: Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 80: 776–787, 1997

    Google Scholar 

  2. Gordower L, Decaestecker Y, Kacem Y, Lemmers J, Gusman J, Burchert M, Danguy A, Gabius HJ, Salmon R, Camby I: Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis. Neuropath Appl Neurobiol 25: 319–330, 1999

    Google Scholar 

  3. Akimoto Y, Hirabayashi J, Kasai K, Hirano H: Expression of the endogenous 14-kDa beta-galactoside-binding lectin galectin in normal human skin. Cell Tissue Res 280: 1–10, 1995

    Google Scholar 

  4. Sanford GL, Harris HS: Stimulation of vascular cell proliferation by beta-galactoside specific lectins. FASEB J 4: 2912–2918, 1990

    Google Scholar 

  5. Dagher SF, Wang JL, Patterson RJ: Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci USA 92: 1213–1217, 1995

    Google Scholar 

  6. Kuwabara I, Liu FT: Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 156: 3939–3944, 1996

    Google Scholar 

  7. Yang RY, Hsu DK, Liu FT: Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 93: 6737–6742, 1996

    Google Scholar 

  8. Liu FT, Hsu DK, Zuberi RI, Kuwabara I, Chi EY, Henderson-WR J: Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol 147: 1016–1028, 1995

    Google Scholar 

  9. Bao Q, Hughes RC: Galectin-3 expression and effects on cyst enlargement and tubulogenesis in kidney epithelial MDCK cells cultured in three-dimensional matrices in vitro. J Cell Sci 108: 2791–2800, 1995

    Google Scholar 

  10. Lotan R, Belloni PN, Tressler RJ, Lotan D, Xu XC, Nicolson GL: Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion. Glycoconj J 11: 462–468, 1994

    Google Scholar 

  11. Gaudin JC, Arar C, Monsigny M, Legrand A: Modulation of the expression of the rabbit galectin-3 gene by p53 and c-Ha-ras proteins and PMA. Glycobiology 7: 1089–1098, 1997

    Google Scholar 

  12. Raz A, Zhu DG, Hogan V, Shah N, Raz T, Karkash R, Pazerini G, Carmi P: Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis. Int J Cancer 46: 871–877, 1990

    Google Scholar 

  13. Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia MP, Raz A: Metastasis of human colon cancer is altered by modifying expression of the betagalactoside-binding protein galectin 3. Gastroenterology 115: 287–296, 1998

    Google Scholar 

  14. Xu XC, El-Naggar AK, Lotan R: Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 147: 815–822, 1995

    Google Scholar 

  15. Castronovo V, Van-Den-Brule FA, Jackers P, Clausse N, Liu FT, Gillet C, Sobel ME: Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol 179: 43–48, 1996

    Google Scholar 

  16. Lotz MM, Andrews-CW J, Korzelius CA, Lee EC, Steele-GD J, Clarke A, Mercurio AM: Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA 90: 3466–3470, 1993

    Google Scholar 

  17. Schoeppner HL, Raz A, Ho SB, Bresalier RS: Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer 75: 2818–2826, 1995

    Google Scholar 

  18. Roggendorf W, Strupp S, Paulus W: Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol 92: 288–293, 1996

    Google Scholar 

  19. Yamaoka K, Mishima K, Nagashima Y, Asai A, Sanai Y, Kirino T: Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells. J Neurosci Res 59: 722–730, 2000

    Google Scholar 

  20. Strik H, Deininger M, Streffer J, Grote E, Wickboldt J, Dichgans J, Weller M, Meyermann R: Bcl-2 family protein expression in initial and recurrent glioblastomas: Modulation by radiochemotherapy. J Neurol Neurosurg Psych 67: 763–768, 1999

    Google Scholar 

  21. Roth W, Grimmel C, Rieger L, Strik H, Takayama S, Krajewski S, Meyermann R, Dichgans J, Reed JC, Weller M: Bag-1 and Bcl-2 gene transfer in malignant glioma: Modulation of cell cycle regulation and apoptosis. Brain Path 10: 223–234, 2000

    Google Scholar 

  22. Perillo NL, Pace KE, Seilhamer JJ, Baum LG, Sato S, Hughes RC: Apoptosis of T cells mediated by galectin-1. Nature 378: 736–739, 1995

    Google Scholar 

  23. Weller M, Fontana A: The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain. Brain Res Rev 21: 128–151, 1995

    Google Scholar 

  24. Camby I, Belot, Rorive S, Lefranc F, Lahm H, Kaltner H, Hadari Y, Ruchoux MM, Brotchi J, Zick Y, Salmon I, Gabius HJ, Kiss R: Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol 11: 12–26, 2001

    Google Scholar 

  25. Wesseling P, Ruiter DJ, Burger PC: Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neuro-oncol 32: 253–265, 1997

    Google Scholar 

  26. Nangia MP, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A: Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156: 899–909, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strik, H.M., Deininger, M.H., Frank, B. et al. Galectin-3: Cellular Distribution and Correlation with WHO-grade in Human Gliomas. J Neurooncol 53, 13–20 (2001). https://doi.org/10.1023/A:1011874800612

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011874800612

Navigation